Back
Intellia Therapeutics Vs. Builders FirstSource Industry Stock Comparison
Sell
21
NTLA
Intellia Therapeutics
Last Price:
21.38
Seasonality Move:
20.01%
Sell
44
BLDR
Builders FirstSource
Last Price:
160.85
Seasonality Move:
2.94%
Sell
21
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $21.38. The Score for NTLA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Builders FirstSource (BLDR)
is a Sell
Is Builders FirstSource a Buy, Sell or Hold?
- The current Builders FirstSource [BLDR] share price is $160.79. The Score for BLDR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $21.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
BLDR Stock Price Chart
What is Builders FirstSource's stock price today?
-
The Builders FirstSource share price today is $160.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 34.64 | Sell |
Chaikin Money Flow: | -1632861 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.19 - 25.67) | Sell |
Bollinger Bands (100): | (23.14 - 28.68) | Sell |
BLDR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.21 | Sell |
Relative Strength Index (14 RSI): | 39.68 | Sell |
Chaikin Money Flow: | 2134853 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (160.77 - 184.17) | Sell |
Bollinger Bands (100): | (169.65 - 198.37) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.66 | Sell |
20-day SMA: | 24.42 | Sell |
50-day SMA: | 24.14 | Sell |
200-day SMA: | 28.53 | Sell |
8-day EMA: | 23.12 | Sell |
20-day EMA: | 23.84 | Sell |
50-day EMA: | 24.54 | Sell |
200-day EMA: | 29.23 | Sell |
BLDR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 163.87 | Sell |
20-day SMA: | 169.03 | Sell |
50-day SMA: | 183.77 | Sell |
200-day SMA: | 159.18 | Buy |
8-day EMA: | 163.17 | Sell |
20-day EMA: | 168.84 | Sell |
50-day EMA: | 177.15 | Sell |
200-day EMA: | 161.93 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.26 per share, and a decrease next year of $0.37 per share.
Builders FirstSource Earnings Growth & BLDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.48 per share, a decrease this year of $0.93 per share, and an increase next year of $1.31 per share.
Intellia Therapeutics Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Builders FirstSource Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |